Mochi Health Tirzepatide Cost: Starting Dose, Membership and Per-Dose

Last reviewed: September 17, 2026 Last updated: September 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mochi Health advertises compounded tirzepatide at $90/month for the starting dose plus $39 first-month membership (an introductory rate)—a combined $129 first month. The ongoing monthly membership rate should be confirmed at checkout, and medication cost increases as dose escalates under Mochi's per-dose pricing model. PlexusDx charges $289/month for tirzepatide injection with no membership fee and the same price at every dose. Over 12 months on starting-dose rates, Mochi's advertised structure totals $1,548 (assuming the first-month $39 membership rate continues throughout; ongoing rate should be confirmed); PlexusDx totals $3,468. Mochi wins on advertised starting price; PlexusDx offers dose-invariant simplicity and may cost less at maintenance doses depending on Mochi's higher-tier rates, which are not published in available sources.

At-a-glance comparison: Mochi Health vs PlexusDx tirzepatide

Mochi Health pricing captured September 4, 2026 from joinmochi.com/blog/per-dose-pricing-mochi-health and joinmochi.com/medications/compounded-tirzepatide. PlexusDx pricing current as of September 17, 2026. Trustpilot ratings captured September 4–9, 2026.

Mochi Health tirzepatide pricing structure

Mochi Health operates a per-dose pricing model for compounded tirzepatide. The starting dose costs $90/month for medication, separate from membership. Mochi's website states the first-month membership fee is $39 (an introductory rate); the ongoing monthly membership rate should be confirmed at checkout. Combined, the advertised first-month all-in cost is $129 for compounded tirzepatide at the starting dose.

Mochi's per-dose model means medication cost increases as dose escalates. The sources reviewed state "per-dose pricing; higher doses vary" and note that the current per-dose model supersedes older flat-price structures, but do not provide specific figures for maintenance or higher-dose tiers. Patients should confirm the rate for their prescribed dose at checkout.

Mochi also offers compounded semaglutide at $60/month starting dose plus the same membership structure, and branded GLP-1 options are mentioned but not priced in available sources.

PlexusDx tirzepatide pricing structure

PlexusDx charges $289/month for compounded tirzepatide injection on a month-to-month plan, with no separate membership or service fee. The rate is the same at every dose—starting, escalation, and maintenance. PlexusDx also offers 3-month and 6-month commitment discounts: $269/month prepaid over three months (our calculation: $807 upfront) and $249/month prepaid over six months (our calculation: $1,494 upfront).

PlexusDx's flat-rate model simplifies budgeting and eliminates dose-driven cost increases. The all-in price includes the provider visit, prescription, medication, and shipping.

Like-for-like 12-month cost calculation

Comparing month-to-month plans over 12 months, starting from each provider's documented rates:

Mochi Health 12-month calculation (our calculation): $90 medication + $39 membership × 12 months = $1,548. This assumes the first-month $39 membership fee continues at that rate every month (ongoing rate should be confirmed) and the patient remains on the starting dose. Medication cost will increase if dose is escalated; higher-dose pricing is not documented in the sources reviewed.

PlexusDx 12-month calculation (our calculation): $289/month × 12 months = $3,468. This rate applies regardless of dose.

Mochi's advertised starting-dose structure is $160/month lower than PlexusDx's flat rate, translating to $1,920 lower cost over 12 months if the patient remains on starting-dose tirzepatide and the first-month $39 membership fee continues throughout. However, most patients escalate dose over time. If Mochi's per-dose pricing increases significantly at higher tiers, the cost gap narrows or reverses. Without published higher-dose rates from Mochi, a full maintenance-phase comparison is not possible.

Semaglutide pricing comparison

Mochi Health also offers compounded semaglutide at $60/month starting dose plus $39 first-month membership (an introductory rate)—$99 first month all-in. PlexusDx charges $189/month for semaglutide injection with no membership fee and the same price at every dose. Over 12 months on starting-dose rates (assuming Mochi's first-month $39 membership rate continues; ongoing rate should be confirmed), Mochi totals $1,188 (our calculation); PlexusDx totals $2,268 (our calculation). Mochi's advertised semaglutide starting price is $90/month lower than PlexusDx, but the same per-dose escalation caveat applies.

Strengths and gaps in Mochi Health's pricing model

Strengths

• Low advertised entry cost: $129 first month for tirzepatide (starting dose + first-month introductory membership) is among the lowest published starting rates in telehealth GLP-1 programs.
• Transparent per-dose structure: Mochi explicitly states that medication cost varies by dose, avoiding the surprise of hidden escalation fees.
• Strong review record: Mochi Health holds a 4.5-star rating on Trustpilot with approximately 18,000 reviews (captured September 4, 2026; trustpilot.com), indicating broad customer engagement.

Gaps and uncertainties

• Ongoing membership rate not confirmed: Mochi's website labels the first-month membership fee as an introductory rate; the ongoing monthly rate should be confirmed at checkout. If the membership fee increases after the first month, the effective monthly cost rises.
• Higher-dose pricing not published: Mochi states that medication cost increases at higher doses but does not publish a dose-tier pricing table. Patients cannot calculate maintenance-phase costs without contacting Mochi directly.
• Dose-escalation cost uncertainty: The gap between starting-dose and maintenance-dose pricing determines whether Mochi's per-dose model remains cost-competitive over time. Without those figures, long-term budgeting is opaque.
• Separate line items complicate comparison: Splitting medication and membership into separate charges makes like-for-like comparison harder and requires assumptions about ongoing membership cost.

Reported service experience

While Mochi Health's 4.5-star Trustpilot rating reflects generally positive feedback, individual negative reports describe issues such as providers appearing late to virtual appointments or limited engagement during consultations (paraphrased from captured Trustpilot examples; individual reports are allegations, not verified facts). These reports are anecdotal and may not represent typical outcomes, but prospective patients may wish to confirm provider availability and consultation format during intake.

Strengths and gaps in PlexusDx's pricing model

Strengths

• Dose-invariant pricing: PlexusDx charges the same rate at starting, escalation, and maintenance doses, eliminating cost surprises as treatment progresses.
• No membership fee: The monthly rate is all-inclusive—provider visit, prescription, medication, and shipping—with no separate service charge.
• Predictable budgeting: Patients know the exact monthly cost from intake through maintenance, simplifying financial planning.
• Commitment discounts available: 3-month and 6-month plans reduce the monthly rate to $269 and $249 respectively for patients confident in long-term use.
• Verified review record: PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Gaps

• Higher advertised entry cost: PlexusDx's $289/month tirzepatide rate is $160/month higher than Mochi's advertised starting dose all-in cost, making PlexusDx less accessible for patients prioritizing the lowest possible first-month price.
• No introductory discount: PlexusDx's advertised rate is the same in month one and month twelve, offering no promotional entry point.

Choose Mochi Health if…

• You want the lowest possible entry cost and plan to remain on the starting dose for an extended period.
• You are comfortable confirming ongoing membership and higher-dose medication rates at checkout before committing.
• You prefer a provider with a large Trustpilot review base (4.5 stars, ~18,000 reviews) and are willing to accept some reported variability in provider engagement.
• You are exploring both semaglutide and tirzepatide and want low starting rates for both compounds.

Choose PlexusDx if…

• You want predictable, dose-invariant pricing from starting dose through maintenance—no cost increases as you escalate.
• You prefer an all-inclusive monthly rate with no separate membership or service fee.
• You value transparent long-term budgeting and want to know your exact 12-month cost at intake.
• You are confident in committing to 3 or 6 months and want to lock in a lower per-month rate ($269 or $249 for tirzepatide).
• You want a provider with a verified positive review record (4.3 stars, 79% five-star on Trustpilot) and a straightforward service model.

Key decision factors

Advertised starting cost vs maintenance cost: Mochi's $129 first-month rate is compelling for patients who remain on starting-dose tirzepatide. Most patients escalate dose over time, and Mochi's per-dose model means cost will increase. Without published higher-dose rates, calculating the true cost of a 6- or 12-month maintenance course is not possible from Mochi's website alone. PlexusDx's flat $289 rate makes long-term cost transparent at intake.

Membership structure: Mochi separates medication and membership into two line items; the first-month $39 membership is labeled an introductory rate and the ongoing rate should be confirmed. PlexusDx includes everything in one published price. Patients who prefer itemized billing may find Mochi's structure more granular; patients who prefer simplicity may prefer PlexusDx's bundled model.

Service quality and provider engagement: Both providers hold positive aggregate review ratings (Mochi 4.5 stars, PlexusDx 4.3 stars). Individual Trustpilot reports describe variability in Mochi provider engagement; PlexusDx's smaller review volume reflects a newer market presence. Prospective patients may wish to confirm consultation format and provider availability during intake with either program.

Dose-escalation transparency: Mochi explicitly states that cost increases at higher doses but does not publish a dose-tier table. PlexusDx explicitly states that cost does not change at higher doses. For patients planning long-term GLP-1 therapy, dose-invariant pricing eliminates a major budgeting unknown.

Methodology and freshness

This analysis is based on pricing, membership terms, and review data captured directly from Mochi Health's website (joinmochi.com/blog/per-dose-pricing-mochi-health and joinmochi.com/medications/compounded-tirzepatide) on September 4, 2026, and PlexusDx's current published pricing as of September 17, 2026. Mochi's Trustpilot rating (4.5 stars, ~18,000 reviews) was captured September 4, 2026; PlexusDx's Trustpilot rating (4.3 stars, 79% five-star) was captured September 9, 2026 from trustpilot.com/review/plexusdx.com. Twelve-month cost totals are our calculations based on the documented monthly rates and stated assumptions. Mochi's ongoing membership rate and higher-dose medication rates were not published in the sources reviewed; these figures should be confirmed at checkout. Neither provider guarantees eligibility, specific medication, dose, or clinical outcomes.

Frequently Asked Questions

Does Mochi Health's $129 first-month tirzepatide price stay the same at higher doses?

No. Mochi Health operates a per-dose pricing model, meaning medication cost increases as dose escalates. The $90/month medication figure applies to the starting dose only. Higher-dose rates are not published in available sources and should be confirmed at checkout.

Is Mochi Health's membership fee ongoing or only for the first month?

Mochi's website describes the first-month membership fee as an introductory rate. The ongoing monthly membership rate should be confirmed at checkout. Our 12-month calculations assume the first-month rate continues, but this is a conservative assumption and may not reflect the actual ongoing rate.

How does PlexusDx's $289/month tirzepatide rate compare to Mochi's starting price over 12 months?

On starting-dose rates, Mochi's advertised structure totals $1,548 over 12 months (assuming the first-month membership rate continues; ongoing rate should be confirmed); PlexusDx totals $3,468 (our calculations). Mochi's starting price is lower. However, PlexusDx's rate does not change at higher doses, while Mochi's per-dose model increases cost as dose escalates. Without Mochi's maintenance-dose rates, a full comparison is incomplete.

Does PlexusDx charge extra when my tirzepatide dose increases?

No. PlexusDx charges $289/month for tirzepatide injection regardless of dose—starting, escalation, or maintenance. The rate is the same whether you are prescribed 2.5 mg, 5 mg, 10 mg, or 15 mg weekly. Commitment plans (3-month or 6-month) reduce the monthly rate to $269 or $249 respectively.

Are Mochi Health and PlexusDx tirzepatide products FDA-approved?

No. Both providers offer compounded tirzepatide, which is not FDA-approved. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Mochi and PlexusDx work with licensed compounding pharmacies; neither offers branded Mounjaro or Zepbound under these pricing structures.

Sources

• Mochi Health per-dose pricing explanation, joinmochi.com/blog/per-dose-pricing-mochi-health (accessed September 4, 2026)
• Mochi Health compounded tirzepatide product page, joinmochi.com/medications/compounded-tirzepatide (accessed September 4, 2026)
• Mochi Health weight loss programs overview, joinmochi.com/weight-loss (accessed September 4, 2026)
• Mochi Health Trustpilot profile, trustpilot.com (accessed September 4, 2026)
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• PlexusDx tirzepatide injection pricing, plexusdx.com/products/tirzepatide-injection (current as of September 17, 2026)
• PlexusDx semaglutide injection pricing, plexusdx.com/products/semaglutide-injection (current as of September 17, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.